Skip to main content

Table 3 Correlation between miRNA expression and BC clinical information

From: Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer

Clinical character

n

miR-93-5p

p-value

miR-516a-5p

p-value

Age (year)

  

0.84

 

0.49

  ≤ 64

22

6.95 (6.35–8.40)

 

7.15 (6.63–7.78)

 

 >64

31

6.98 (5.35–8.31)

 

6.98 (5.71–7.58)

 

Gender

  

0.85

 

0.68

 Male

40

6.96 (6.07–8.38)

 

7.04 (6.15–7.58)

 

 Female

13

6.79 (5.58–8.13)

 

7.07 (5.89–7.74)

 

pT stage

  

<0.01

 

0.06

 Ta-T1

32

6.39 (5.35–7.85)

 

6.98 (5.41–7.64)

 

 T2-T4

21

8.06 (6.96–8.63))

 

7.14 (6.84–8.22)

 

Grade

  

0.15

 

0.08

 Low

22

6.39 (5.36–8.17)

 

6.87 (5.54–7.69)

 

 High

31

7.24 (6.74–8.46)

 

7.08 (6.82–7.70)

 

Lymph node

  

0.47

 

0.77

 Negative

47

6.96 (5.60–8.39)

 

7.03 (5.86–7.65)

 

 Positive

6

6.63 (6.05–7.28)

 

7.27 (6.39–7.82)

 
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us